Ensuring Vaccine Safety: Rigorous Regulations in Action

Union Health Minister J P Nadda confirmed that Kerala Medical Services Corporation strictly adheres to quality protocols, procuring rabies vaccines only with batch release certificates from the Central Drugs Laboratory. Nadda reassured that neither vaccines nor anti-rabies immunoglobulins were distributed without mandatory approvals, ensuring adherence to national standards.

Devdiscourse News Desk | New Delhi | Updated: 01-08-2025 15:49 IST | Created: 01-08-2025 15:49 IST

Ensuring Vaccine Safety: Rigorous Regulations in Action — This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.

Country:
India

Union Health Minister J P Nadda addressed the Lok Sabha, clarifying the adherence to stringent regulatory standards by the Kerala Medical Services Corporation (KMSCL) regarding rabies vaccine procurement.

Responding to questions about compliance, he confirmed that all vaccines had undergone required testing and received batch release certification from the Central Drugs Laboratory (CDL).

The KMSCL, Nadda stated, has religiously followed protocols since 2016-17, ensuring quality and safety standards, crucial under the Drugs and Cosmetics Act, 1940, thus safeguarding public health through meticulous regulatory oversight.

(With inputs from agencies.)